BioSpace News Archive

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, announced the appointment of Professor Jean-Charles Soria, M.D., Ph.D., to its Board of Directors.

Financing will advance its musculoskeletal product through a clinical proof of activity trial as well as continue the discovery and development of its ongoing pipeline of microbial-based products for human health and well-being.

Delaying surgery for 12 months or more after a rotator cuff tear diagnosis is associated with almost twice the odds of needing a subsequent revision surgery compared to having surgery between six weeks and one year after diagnosis, according to a retrospective study of records from thousands of patients across the United States by investigators at Hospital for Special Surgery.

Fresenius Medical Care North America Announces Next Generation Solution Bags to Support Continued Home Dialysis Expansion

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced it has received an expansion of its Emergency Use Authorization (EUA) for the TaqPath COVID-19 Combo Kit to include an additional sample collection method provided by Everlywell, a leading digital health testing company. The TaqPath test is aut

Leading advocacy organization for families affected by Niemann-Pick disease supports global effort to raise awareness and support research for ultra-rare genetic disorder.

Final, Five-Year Results of Long-Term Extension Study of Clinical Response and Remission of STELARA® (ustekinumab) in Patients with Moderate-to-Severe Crohn’s Disease to be Featured in Oral Presentation

Nimbus Therapeutics , a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the appointment of Erin Cowhig as Chief People Officer. In this newly created role, Ms. Cowhig will oversee all aspects of Nimbus’ human resources, talent acquisition and management, and diversity and inclusion efforts. “Our people are the reason for Nimbus’ many ye

A PARP (poly ADP-ribose polymerase) inhibitor is a substance that blocks PARP enzyme in the cell. DNA damage occurs during cancer. Blocking of PARP helps the cancer cells in repairing their damaged part of DNA.

The global organ-on-a-chip market is likely to exhibit phenomenal growth over the period of assessment.